Drugs / Oxaliplatin injection
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT07392866 | Mar 2026 → Mar 2030 expected | hepatocellular carcinoma | Nanjing Sanhome Pharmaceutical, Co., Ltd. | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Oxaliplatin injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07392866 ↗ |
| Route | Intravenous | “administered as IV infusion” NCT07392866 ↗ |